Skip to main content
. 2015 Nov 3;16:496. doi: 10.1186/s13063-015-0990-9

Table 19.

The cost-effectiveness analysis in the 24-month period (the incidence of diabetes)

Group C (yuan) E (%) C/E ΔC/ΔE
The treatment group 44911142.2 20.3 2212371.5 −333624.6
The control group 40740835.2 32.8 1242098.6